The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial

Journal of Urology

Volumn 175, Issue 5, 2006, Pages 1641-1644

  Divrik, Rauf Taner ^a   Yildirim, Ümit ^a   Zorlu, Ferruh ^a   Özen, Haluk ^b  

^a SB Tepecik Research and Teaching Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

bladder neoplasms; disease free survival; reoperation

Indexed keywords

BCG VACCINE; MITOMYCIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MUSCLE CANCER; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; REOPERATION; URINARY BLADDER NEOPLASMS;

EID: 33646100303     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)01002-5     Document Type: Article

References (10)

1. Divrik T., Yi{dotless}ldi{dotless}ri{dotless}m U., Eroǧlu A., Zorlu F., and Özen H. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?. J Urol 175 (2006) 000
2. Klän R., Loy V., and Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146 (1991) 316
3. Mersdorf A., Brauers A., Wolff J.M., Schneider V., and Jakse G. 2nd TUR for superficial bladder cancer. a must?. J Urol 159 suppl (1998) 143 abtract 542
4. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162 (1999) 74
5. Schips L., Augustin H., Zigeuner R.E., Galle G., Habermann H., Trummer H., et al. Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?. Urology 59 (2002) 220
6. Dalbagni G., Herr H.W., and Reuter V.E. Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 60 (2002) 822
7. Grimm M.O., Steinhoff C., Simon X., Spiegelhalder P., Ackermann R., and Vögeli T.A. Effect of routine repeat transurethral resection for superficial bladder cancer a long-term observational study. J Urol 170 (2003) 433
8. Sobin L.H., Wittekind C.H., and International Union Against Cancer (UICC). Urinary bladder. TNM Classification of Malignant Tumours. 5th edition (1997), Wiley-Liss, New York 187
9. Oosterlinck W., Lobel B., Jakse G., Malmstrom P., Stockle M., Sternberg C., et al. Guidelines on bladder cancer. Eur Urol 41 (2002) 105
10. Böhle A., Jocham D., and Bock P.R. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer. a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 169 (2003) 90